Related references
Note: Only part of the references are listed.Adenosine 2A receptor agonism: A single intrathecal administration attenuates motor paralysis in experimental autoimmune encephalopathy in rats
Lisa C. Loram et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis
Tohid Gharibi et al.
CELLULAR IMMUNOLOGY (2015)
Message from Editor-in-Chief
Stephen Skaper
CNS & Neurological Disorders-Drug Targets (2014)
Immune surveillance of the central nervous system in multiple sclerosis - Relevance for therapy and experimental models
Rehana Z. Hussain et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging
Olga Ciccarelli et al.
LANCET NEUROLOGY (2014)
Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response
Norma Y. Hernandez-Pedro et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulated
Fabrizio Vincenzi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: A brief overview
Naveen Mulakayala et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Regulation of microglia activation and deactivation by nuclear receptors
Kaoru Saijo et al.
GLIA (2013)
Blocking A(2B) Adenosine Receptor Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis via Inhibition of IL-6 Production and Th17 Differentiation
Wei Wei et al.
JOURNAL OF IMMUNOLOGY (2013)
Pathology and disease mechanisms in different stages of multiple sclerosis
Hans Lassmann
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Adenosine receptors as drug targets - what are the challenges?
Jiang-Fan Chen et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain barrier disruption: implications for the pathogenesis of multiple sclerosis
T. G. D'Aversa et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
Adenosine and its receptors as therapeutic targets: An overview
Sakshi Sachdeva et al.
SAUDI PHARMACEUTICAL JOURNAL (2013)
Current Concepts in Multiple Sclerosis: Autoimmunity Versus Oligodendrogliopathy
Jin Nakahara et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2012)
Regulatory T cells in the central nervous system
Daniel E. Lowther et al.
IMMUNOLOGICAL REVIEWS (2012)
Adenosine Augments IL-10 Production by Microglial Cells through an A2B Adenosine Receptor-Mediated Process
Balazs Koscso et al.
JOURNAL OF IMMUNOLOGY (2012)
A2A Adenosine Receptor Signaling in Lymphocytes and the Central Nervous System Regulates Inflammation during Experimental Autoimmune Encephalomyelitis
Jeffrey H. Mills et al.
JOURNAL OF IMMUNOLOGY (2012)
Genetic inactivation of the adenosine A2A receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis
Shu-Qin Yao et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Neutrophils in multiple sclerosis are characterized by a primed phenotype
Matthias Naegele et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats
Takayuki Matsumoto et al.
PHARMACOLOGICAL RESEARCH (2012)
Recent developments in adenosine receptor ligands and their potential as novel drugs
Christa E. Mueller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation
Wei Bi et al.
BRAIN RESEARCH (2011)
Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis
Farhad Jadidi-Niaragh et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2011)
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors-An Update
Bertil B. Fredholm et al.
PHARMACOLOGICAL REVIEWS (2011)
Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis
F. Jadidi-Niaragh et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
Anti-Inflammatory and Immunosuppressive Effects of the A2A Adenosine Receptor
Gillian R. Milne et al.
THESCIENTIFICWORLDJOURNAL (2011)
Therapeutic Approach to Multiple Sclerosis by Novel Oral Drugs
Farhad Jadidi-Niaragh et al.
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY (2011)
Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats
Guo Qian Chen et al.
BRAIN RESEARCH (2010)
Adenosine receptors as drug targets
Bertil B. Fredholm
EXPERIMENTAL CELL RESEARCH (2010)
Prostaglandins in pathogenesis and treatment of multiple sclerosis
Abbas Mirshafiey et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2010)
Immunopharmacological role of the Leukotriene Receptor Antagonists and inhibitors of leukotrienes generating enzymes in Multiple Sclerosis
Abbas Mirshafiey et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2010)
Structure-Based Discovery of A2A Adenosine Receptor Ligands
Jens Carlsson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis
Farhad Jadidi-Niaragh et al.
NEUROPHARMACOLOGY (2010)
Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis
Orhan Aktas et al.
TRENDS IN NEUROSCIENCES (2010)
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Jane Hoyt Buckner
NATURE REVIEWS IMMUNOLOGY (2010)
Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia
Alessia Melani et al.
BRAIN (2009)
Oxygen radical production in leukocytes and disease severity in multiple sclerosis
Natalia Mossberg et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Apoptosis Is Essential for Neutrophil Functional Shutdown and Determines Tissue Damage in Experimental Pneumococcal Meningitis
Uwe Koedel et al.
PLOS PATHOGENS (2009)
Glucocorticoids regulate innate immunity in a model of multiple sclerosis:: reciprocal interactions between the A1 adenosine receptor and β-arrestin-1 in monocytoid cells
Shigeki Tsutsui et al.
FASEB JOURNAL (2008)
Adenosine receptors:: therapeutic aspects for inflammatory and immune diseases
Gyorgy Hasko et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Temporal trends in the incidence of multiple sclerosis
Alvaro Alonso et al.
NEUROLOGY (2008)
CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis
Jeffrey H. Mills et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Host A2B adenosine receptors promote carcinoma growth
Sergey Ryzhov et al.
NEOPLASIA (2008)
Adenosine A2A receptors and brain injury:: Broad spectrum of neuroprotection, multifaceted actions and fine tuning modulation
Jiang-Fan Chen et al.
PROGRESS IN NEUROBIOLOGY (2007)
Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions
Nathalie Koning et al.
ANNALS OF NEUROLOGY (2007)
A2A adenosine receptors and C/EBPβ are crucially required for IL-10 production by macrophages exposed to Escherichia coli
Balazs Csoka et al.
BLOOD (2007)
Adenosine Deamination sustains dendritic cell activation in inflammation
Melanie D. Desrosiers et al.
JOURNAL OF IMMUNOLOGY (2007)
Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition
Charles P. Sevigny et al.
JOURNAL OF IMMUNOLOGY (2007)
Adenosine and lymphocyte regulation
Stefania Gessi et al.
PURINERGIC SIGNALLING (2007)
Shaping of monocyte and macrophage function by adenosine receptors
Gyorgy Hasko et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Purinergic modulation of microglial cell activation
Beata Sperlagh et al.
PURINERGIC SIGNALLING (2007)
Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation
M. J. L. Bours et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Nucleoside transporters: from scavengers to novel therapeutic targets
Anne E. King et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Adenosine receptors as therapeutic targets
KA Jacobson et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
A2B adenosine receptor antagonists:: Recent developments
B Cacciari et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
Gi-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK
A la Sala et al.
JOURNAL OF IMMUNOLOGY (2005)
Infarct-sparing effect of A2A-adenosine receptor activation is due primarily to its action on lymphocytes
ZQ Yang et al.
CIRCULATION (2005)
The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules
A Johnston et al.
CLINICAL IMMUNOLOGY (2005)
A2A adenosine receptor induction inhibits IFN-γ production in murine CD4+ T cells
CM Lappas et al.
JOURNAL OF IMMUNOLOGY (2005)
Adenosine, inflammation and asthma - a review
M Livingston et al.
INFLAMMATION RESEARCH (2004)
A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis
S Tsutsui et al.
JOURNAL OF NEUROSCIENCE (2004)
Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism
HK Eltzschig et al.
BLOOD (2004)
Crucial role for ecto-5-′nucleotidase (CD73) in vascular leakage during hypoxia
LF Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Adenosine: an endogenous regulator of innate immunity
G Hasko et al.
TRENDS IN IMMUNOLOGY (2004)
Activation of murine lung mast cells by the adenosine A3 receptor
H Zhong et al.
JOURNAL OF IMMUNOLOGY (2003)
Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection
O Neuhaus et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Adenosine suppresses α4β7 integrin-mediated adhesion of T lymphocytes to colon adenocarcinoma cells
WM MacKenzie et al.
EXPERIMENTAL CELL RESEARCH (2002)
Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage
A Ohta et al.
NATURE (2001)
Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosis
JB Johnston et al.
ANNALS OF NEUROLOGY (2001)
Structure and function of adenosine receptors and their genes
BB Fredholm et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2000)
Metabolic flux rates of adenosine in the heart
A Deussen
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2000)
A(2A) adenosine receptors in human peripheral blood cells
S Gessi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
